Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in hospitalized influenza
NCT02287467Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2015
- Primary completion
- Jun 2018
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Number of Patients in Each of 6 Clinical Status Categories on Day 7. Started Jan 2015; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT02287467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287467.